Definition
The changes in pathways of clot formation and lysis, and their interactions with cells and tissues that precede or accompany cancer.
Characteristics
Blood coagulation dyscrasias have been linked to cancer for centuries. Tumor regression with leeching and bleeding and thrombosis complicating malignancy were among the early cues to an elegant but ruinous cybernetics. In 1867, Trousseau described “painful edema” (deep vein thrombosis, DVT) with both established and as yet undiscovered malignancies. The common occurrence of venous thromboembolism (VTE) with cancer signals poor survival and is a common cause of death in cancer patients. Compression of veins and organ damage by tumor masses, superimposed infection, surgery, radiation therapy, chemotherapy, hormonal therapy, growth factor/cytokine administration, and antiangiogenic therapy predispose to cancer-related thrombosis. Cancer-related thrombotic syndromes besides VTE include nonbacterial thrombotic (marantic; pertaining...
This is a preview of subscription content, log in via an institution.
References
Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S (2004) A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2:1266–1271
Dvorak HF, Rickles FR (2006) Malignancy and hemostasis. In: Colman RW, Marder VJ, George JN, Goldhaber SZ (eds) Hemostasis and thrombosis, basic principles and clinical practice, 5th edn. Lipincott, Williams & Wilkins, Philadelphia, pp 851–873
Levine MN, Lee AYY, Kakkar AK (2006) Cancer and thrombosis. In: Colman RW, Marder VJ, George JN, Goldhaber SZ (eds) Hemostasis and thrombosis, basic principles and clinical practice, 5th edn. Lipincott, Williams & Wilkins, Philadelphia, pp 1251–1262
Miller GJ, Bauer KA, Howarth DJ et al (2004) Increased incidence of neoplasia of the digestive track in men with persistent activation of the coagulation pathway. J Thromb Haemost 2:2107–2114
Norman PH, Thall PF, Purugganan RV, Riedel BJ, Thakar DR, Rice DC, Huynh L, Qiao W, Wen S, Smythe WR (2009) A possible association between aprotinin and improved survival after radical surgery for mesothelioma. Cancer 115:833–841
Pan CW, Shen ZJ, Ding GQ (2008) The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. J Urol 179:1307–1311
Rossi C, Hess S, Eckl RW, di Lena A, Bruno A, Thomas O, Poggi A (2006) Effect of MCM09, an active site-directed inhibitor of factor Xa, on B16-BL6 melanoma lung colonies in mice. J Thromb Haemost 4:608–613
Zacharski LR (2002) Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy. Cancer Lett 186:1–9
Zacharski LR (2003) Malignancy as a solid phase coagulopathy: implications for the etiology, pathogenesis and treatment of cancer. Semin Thromb Hemost 29:239–246
Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW (2008) Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 100:996–1002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Zacharski, L.R., Rauwerdink, C.A. (2015). Coagulopathy. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_1244-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_1244-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences